Who owns Immunovant, Inc. (IMV)? Elite investor 13F holders
4 tracked elite investors reported holding Immunovant, Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Greenlight Capital, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | IMMUNOVANT INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 47802399.00 USD | 1240654.000000 | Shares | buy | Original filing |
| Renaissance Technologies LLC | IMMUNOVANT INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 28003604.00 USD | 726800.000000 | Shares | add | Original filing |
| Greenlight Capital | IMMUNOVANT INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3603325.00 USD | 93520.000000 | Shares | hold | Original filing |
| Gotham Asset Management | IMMUNOVANT INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1159753.00 USD | 30100.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.